Cancer of Liver

27 registered clinical trials studyying Cancer of Liver — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Wet Heparinized Suction for Abdominal Cancer NCT05041335	H. Lee Moffitt Cancer Center and Research Institute	N/A
Enrolling By Invitation	Getting To Implementation: Improving Cancer Screening for Veterans NCT06458998	University of Pittsburgh	N/A
Withdrawn	Trial of PXS-5505 Combined With First Line Atezolizumab Plus Bevacizumab For Treating Patients With Unresectab NCT05109052	University of Rochester	Phase 1 / Phase 2
Completed	Incorporation of Protein Induced by Vitamin K Absence or Antagonist-II Into Transplant Criteria Expands Benefi NCT05907772	Zhejiang University	—
Completed	Integrative Nutrition Care Plan for the Patient With Liver and Colorectal Cancer NCT05030090	Taipei Medical University	N/A
Active Not Recruiting	Onco-primary Care Networking to Support TEAM-based Care NCT04258813	Duke University	N/A
Completed	Impact of Gender on the Outcome of Liver Transplantation for Hepatocellular Carcinoma NCT05643833	Zhejiang University	—
Active Not Recruiting	Tempus Priority Study: A Pan-tumor Observational Study NCT05179824	Tempus AI	—
Completed	Low-dose Y90 Treatment Planning for HCC NCT04172714	Emory University	N/A
Recruiting	Prospective Cohort of Patients With Hepatocellular Carcinoma in France NCT04348838	Centre Hospitalier Universitaire, Amiens	—
Unknown	The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor NCT03896958	SpeciCare	—
Unknown	A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Mali NCT03607643	Leaf Vertical Inc.	Phase 1 / Phase 2
Unknown	Anlotinib in the Treatment of Advanced Hepatocellular Carcinoma (HCC) NCT03766776	The First Affiliated Hospital with Nanjing Medical University	N/A
Recruiting	SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry NCT03452774	Massive Bio, Inc.	—
Active Not Recruiting	Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer NCT03347162	Rigshospitalet, Denmark	—
Unknown	Impact of a Training in Therapeutic Education on the Relation Between Care Givers and Their Patients NCT03323996	Centre Hospitalier Universitaire de Besancon	—
Completed	Drug-loadable（T-ACE Beads）for Hepatoma Embolization Therapy NCT03299036	National Cheng-Kung University Hospital	N/A
Completed	Radiotherapy Assessments During Intervention ANd Treatment (RADIANT) NCT03133286	DxTerity Diagnostics	—
Completed	Taiwan ACE Beads for Hepatoma Embolization Therapy NCT02825550	National Cheng-Kung University Hospital	N/A
Completed	A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors NCT02145559	University of Chicago	Phase 1
Completed	Effects of Dexmedetomidine During IRE Procedures for Solid Tumours NCT02044224	Uppsala University Hospital	Phase 4
Completed	Effects of Dexmedetomidine During Radiofrequency Ablation of Abdominal Tumours NCT02016391	Uppsala University Hospital	Phase 4
Completed	Surgical Outcomes Database For Faculty of Hepatopancreatic Biliary Surgery NCT01657383	Wake Forest University Health Sciences	—
Completed	Fluid Optimization in Liver Surgery NCT01627808	Catholic University of the Sacred Heart	—
Unknown	Treatment of Hepatocellular Carcinoma With Radiofrequency Ablation (RFA) Associated With Postoperative TACE NCT00730860	Southwest Hospital, China	N/A
Terminated	Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular C NCT00669136	Lisa H. Butterfield, Ph.D.	Phase 1
Terminated	Dose Escalation Study Combining Oral Capecitabine (Xeloda) and Radiotherapy for Patients With Unresectable Liv NCT00216437	James A. Haley Veterans Administration Hospital	Phase 1